Among adults 60 and older with normal BMI, 59.7% have high cholesterol. Among obese adults in the same age group, the rate is 64.4%. That 4.7 percentage point gap is the entire case against using BMI as a primary cardiovascular risk screen in older populations.

The assumption that a healthy weight signals a healthy lipid profile holds up reasonably well in young adults. It largely collapses by middle age, and by the time patients reach 60, it has nearly disappeared.

Age Erases the BMI-Cholesterol Relationship

The data across age groups tells a clean story. Among adults 20-39, normal BMI is genuinely protective: only 9.7% have high cholesterol, compared to 23.5% among obese adults in the same cohort. That 13.8 percentage point gap gives clinicians something to work with.

By ages 40-59, the gap has narrowed considerably. Normal-BMI adults in that bracket show a 34.6% high cholesterol prevalence, which is already higher than the 23.5% rate seen in obese adults a generation younger. A normal-weight 50-year-old carries more lipid risk than an obese 30-year-old. That's not a subtle finding.

At 60 and older, the gap between normal BMI (59.7%) and obese (64.4%) is just 4.7 percentage points. For practical clinical purposes, weight category has stopped predicting cholesterol status. Patients who have maintained healthy weight their entire lives are arriving at their 60s with nearly the same lipid risk profile as their obese peers. If BMI is the primary trigger for a cholesterol conversation, roughly six in ten normal-weight older adults are at risk of that conversation never happening.

HDL Tells a Different Story

One place where BMI still carries signal is HDL. Normal-weight women average 64.7 mg/dL in HDL, compared to 53.1 mg/dL among obese women. For men, the gap is 54.7 mg/dL versus 45.2 mg/dL. These are meaningful differences: higher HDL is associated with lower cardiovascular event risk, and the 11.6 mg/dL female gap and 9.5 mg/dL male gap are clinically relevant.

This creates a more complicated picture than the total cholesterol data alone suggests. Normal-weight older adults may have high total cholesterol rates approaching those of obese adults, but they're also carrying more protective HDL. The net cardiovascular risk calculation is not straightforward, which is precisely why a full lipid panel matters more than a BMI reading.

Who's in the Normal-Weight, High-Cholesterol Population

Among normal-weight adults with total cholesterol at or above 240, the demographic distribution skews heavily toward Non-Hispanic White adults at higher income levels. That group accounts for 32.7% of the population, representing an estimated 1.67 million people concentrated in the top income quintile (Q5). Non-Hispanic Asian adults with normal BMI and high cholesterol show the highest concentration in Q5 at 3.4%, representing an estimated 0.17 million people.

The income gradient here matters for a specific reason: higher-income adults are more likely to have regular primary care access and annual physicals. If those visits are not generating lipid screening because BMI looks fine, the clinical miss is happening in a population that is otherwise well-connected to the healthcare system. These aren't patients falling through access gaps. They're patients whose providers may be reading a normal BMI and moving on.

The 40s as the Inflection Point

The 40-59 age group is where the BMI-cholesterol relationship starts to break down in ways that have direct screening implications. At 34.6% high cholesterol prevalence among normal-weight adults in that bracket, the assumption of lipid safety based on weight alone is already unreliable. By the time patients reach 60, it's essentially gone.

Given that normal-BMI adults aged 40-59 already show a 34.6% high cholesterol prevalence, the question the data raises is precise: at what point in the life course does BMI lose its predictive value for lipid risk, and what alternative screening triggers should replace it?